Achievement of LLDAS5 in patients with systemic lupus erythematosus treated with anifrolumab.

Trial Identifier: D3461R00093
Sponsor: AstraZeneca
Start Date: December 2025
Primary Completion Date: September 2028
Study Completion Date: September 2028
Condition: Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Italy, Ancona Ancona, Italy, 60126
Italy, Bari Bari, Italy, 70124
Italy, Brescia Brescia, Italy, 25123
Italy, CA Monserrato, CA, Italy, 09032
Italy, Ferrara Cona, Ferrara, Italy, 44124
Italy, Firenze Firenze, Italy, 50134
Italy, Milano Milano, Italy, 20122
Italy, Milano Rozzano, Milano, Italy, 20089
Italy, Modena Modena, Italy, 41124
Italy, Padova Padova, Italy, 35128
Italy, Palermo Palermo, Italy, 90127
Italy, Pavia Pavia, Italy, 27100
Italy, Pisa Pisa, Italy, 56126
Italy, Roma Roma, Italy, 00161
Italy, Roma Roma, Italy, 00133
Italy, Torino Torino, Italy, 10128
Italy, Trieste Trieste, Italy, 34128
Italy, Udine Udine, Italy, 33100
Italy, Verona Verona, Italy, 37134